Navigation Links
Numira Biosciences Names New Board Member
Date:8/11/2011

SALT LAKE CITY, Aug. 11, 2011 /PRNewswire/ -- Numira Biosciences, a specialty contract research organization and leader in high resolution, 3D imaging services and visualization software for the life science market, today announced that it has appointed William M. Harrison to its Board of Directors.

Mr. Harrison currently serves as the Chief Executive Officer at VIDA Sciences, a CRO consulting firm based in Kalamazoo, Michigan.  Prior to founding VIDA Sciences, Mr. Harrison held a number of senior management positions at MPI Research, a large international CRO based in Mattawan, Michigan.  Most notably, during his last ten years at MPI, he held the position of President and Chief Operating Officer. Additionally, Mr. Harrison is an active member of the Society of Quality Assurance and serves on the Board of Trustees for the Kalamazoo Valley Community College Foundation and the Borgess Medical Center, as well as serving as a board member for the American Life Sciences Innovation Council.

"We are pleased that Bill has joined our board," said Michael Beeuwsaert, President and CEO of Numira. "His 25 years of senior management and regulatory compliance experience in a high-growth, preclinical services environment will be of great value to Numira as we move to the next level as a company."

About Numira Biosciences

Numira is a rapidly growing provider of specialty contract research services to the pharmaceutical and medical device industries.  Through the combination of several novel technologies and capabilities, we provide clients with an unmatched array of pre-clinical services for their research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other areas of disease and/or therapy.  Moreover, we are a recognized leader in high-resolution, quantitative imaging for drug and device development.  Numira, a privately-held company, is venture-backed by vSpring Captital, the Tech Coast Angels, and Crocker Ventures.   For more information on Numira, please visit www.numirabio.com.


'/>"/>
SOURCE Numira Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ardea Biosciences Reports Recent Accomplishments and Second Quarter 2011 Financial Results
2. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
3. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
4. Neurocrine Biosciences Reports Second Quarter 2011 Results
5. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
6. Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease (ZFN) Technology
7. Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast
8. Cell Biosciences Changes Name to ProteinSimple
9. Sofie Biosciences is Awarded a DOE Phase I SBIR to Commercialize Microscale Radiochemistry Platform
10. SANYO and BD Biosciences Collaborate to Offer Researchers Valuable Technology and Research Tools
11. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... March 30, 2017 , ... ... four posters at the American Association for Cancer Research (AACR) Annual Meeting ... of Vortex’s technology to rapidly collect highly enriched populations of CTCs, undamaged by ...
(Date:3/29/2017)... ... March 29, 2017 , ... Zansors announced today ... as issued by the U.S. Patent & Trademark Office (USPTO). The patent covers ... and health monitoring. This invention will be critical to the future of wearable ...
(Date:3/29/2017)... -- "Surging application of gesture control features in automobiles ... to drive the growth of gesture recognition and touchless ... expected to be worth USD 18.98 billion by 2022, ... 2022. The touchless sensing market is expected to be ... CAGR of 17.44% between 2017 and 2022. Gesture recognition ...
(Date:3/29/2017)... Palo Alto, CA, USA (PRWEB) , ... March 29, 2017 , ... ... experts in various regulatory subjects has announced its 3rd Annual Medical Device Summit 2017 ... 2017 at the Omni Parker House Hotel, in Boston, MA. , The Omni Parker ...
Breaking Biology Technology:
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
Breaking Biology News(10 mins):